Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase  by Zhu, Huan Zhang et al.
FEBS Letters 580 (2006) 4346–4352Conditional gene modiﬁcation in mouse liver using
hydrodynamic delivery of plasmid DNA encoding Cre recombinase
Huan Zhang Zhu*, Wei Wang, Deng Min Feng, Yin Sai, Jing Lun Xue*
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China
Received 9 June 2006; revised 30 June 2006; accepted 30 June 2006
Available online 10 July 2006
Edited by Ned ManteiAbstract The success of Cre-mediated conditional gene target-
ing in liver of mice has until now depended on the generation of
Cre recombinase transgenic mice or on viral-mediated transduc-
tion. Here, we sought to establish the feasibility of using hydro-
dynamic gene delivery of Cre recombinase into liver, using a
ROSA26 EGFP mouse. The expression of EGFP and b-galacto-
sidase was exclusively detected in the liver of mice treated with
hydrodynamic gene delivery of Cre recombinase, as assessed
with ﬂuorescence microscopy and X-Gal staining, respectively;
Southern blotting also showed that Cre mediated recombination
occurred speciﬁcally in the liver and not in other organs. The Cre
mediated recombination reached about 61% of hepatocytes of
mouse after repeated injection, as analyzed by ﬂow cytometry.
These results demonstrate that Cre recombinase can be trans-
ferred to the liver of mice through a simple hydrodynamic
gene-delivery approach and can mediate eﬃcient recombination
in hepatocytes. Thus, hydrodynamic gene delivery of the Cre
recombinase provides a valuable approach for Cre-loxP-medi-
ated conditional gene modiﬁcation in the liver of mice.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The Cre/loxP system from bacteriophage P1 has become an
essential tool for conditional gene activation and/or inactiva-
tion in mouse [1–3]. It has been successfully used in dissecting
gene function during development and adulthood, or in a par-
ticular tissue/cell type [4–6]. The liver has crucial functions in
the regulation of energy homeostasis, detoxiﬁcation, and the
production of serum proteins. The ability to create deﬁned ge-
netic modiﬁcations in vivo provides a powerful strategy for
understanding the relevant functions of numerous hepatic
genes in health and disease. A common approach for achievingAbbreviations: Alb e/p, albumin enhancer and promoter; ALT, alanine
aminotransferase; AST, aspartate aminotransferase; CMV, cytomeg-
alovirus; EGFP, enhancer green ﬂuorescent protein; 4-OHT, 4-hydr-
oxytamoxifen; PBS, phosphate-buﬀered saline
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doi:10.1016/j.febslet.2006.06.094conditional gene modiﬁcation in mouse liver (besides generat-
ing mice with loxP-ﬂanked genes of interest) is to generate
transgenic mice speciﬁcally expressing Cre recombinase in
liver. Several groups have already described the generation
and characterization of transgenic mice carrying the Cre
recombinase under the control of constitutive liver-speciﬁc
promoters [7,8]. Recently, mice have been engineered to allow
spatially and temporally regulation of Cre recombinase using a
ligand-inducible system under the control of liver-speciﬁc pro-
moters [9,10]. Mice expressing Cre recombinase are mated to
mice engineered with loxP sites to allow inducible gene abla-
tion [11,12].
Although the transgenic approach is promising, it has cer-
tain limitations [13–15]. First, a transgenic construct integrated
at diﬀerent genomic locations often varies because of position
eﬀects, necessitating generation and analysis of multiple trans-
genic founder lines. Second, the Cre recombinase-expressing
mouse line must be crossed with mice engineered with loxP
sites, a resource-intensive process that can increase variation
in the genetic background of the oﬀspring, potentially con-
founding behavioral and other analyses. Third, inducible sys-
tems may be leaky, resulting in low-level Cre recombinase
expression in the absence of ligand and allowing gene knock-
out to occur without induction. Finally, Cre transgenic mice
may reveal subtle phenotypes related to Cre toxicity, such that
the phenotypic consequences of Cre overexpression may con-
found phenotypic analysis of the conditional mutation.
Another approach is to use recombinant viruses to deliver
Cre recombinase to the liver of the adult animal. Previous stud-
ies from other laboratories have shown the utility of adenovirus
[16–18]. However, when using E1-deleted adenoviral vectors
complications may arise from the expression of viral functions
on the vector genomes, resulting in host immune responses and
loss of transduced cells. Moreover, incorporation of tissue-spe-
ciﬁc promoters in ﬁrst generation adenoviral vectors often re-
sults in loss of speciﬁcity because of viral elements inﬂuencing
the promoter activity. Thus, traditional delivery of Cre by
either transgenics or viral vectors represents a limiting step of
conditional mutagenesis employing Cre/loxP technology.
To overcome these problems, we adapted previously de-
scribed hydrodynamic delivery technique to transfer DNA eﬃ-
ciently to the livers of living mice [19–24]. We demonstrate that
Cre recombinase can be transferred to mouse liver with a sim-
ple hydrodynamic gene delivery approach and can mediate eﬃ-
cient recombination in liver. This approach will prove useful
for selective ablation of genes in the adult mouse liver without
necessitating generation of transgenic mouse lines expressing
Cre recombinase.blished by Elsevier B.V. All rights reserved.
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2.1. Animals
The homozygous ROSA26 EGFP reporter strain was kindly pro-
vided by Prof. S.H. Orkin of Harvard Medical School (Boston, MA)
[25]. Animals were treated according to Guidelines for Animal Care
and the guidelines of laboratory animals of Fudan University. Mice
were used at 6–8 weeks of age.
2.2. Plasmid DNA
To generate an alb-Cre expression vector containing the Cre recom-
binase gene under the control of the mouse albumin enhancer and pro-
moter, a 0.6-kb SmaI–SacII (blunted) fragment containing the
cytomegalovirus (CMV) promoter from plasmid pCMV Cre-ERt [26]
(kindly provided by Prof. P. Chambon) was replaced with a 2.3-kb Sa-
cII (blunted)-EcoRV fragment containing the albumin enhancer and
promoter (alb e/p) from p2335A (kindly provided by Prof. R.D. Pal-
miter). The ERt fragment was then deleted to form the alb-Cre plasmid
DNA. The identity of the construct was conﬁrmed by restriction
enzyme mapping and DNA sequence analysis.
2.3. Hydrodynamics based transfection in mice
The hydrodynamic gene-transfer procedure was carried out as de-
scribed previously by Liu et al. [19]. In brief, animals were kept at a
high temperature to dilate the tail veins prior to treatment. Naked
DNA was administered to the animals by injection into the tail vein
a volume of sterile 147 mM NaCl, 4 mM KCl, 1.13 mM CaCl2 (Ring-
er’s solution) corresponding to 8% of the bodyweight. Mice were ran-
domly assigned to ﬁve groups: groups were injected with 2.2–2.6 ml of
Ringer’s solution containing either 10 lg of alb-Cre plasmid DNA
(experiment group 1, n = 10), 50 lg of alb-Cre plasmid DNA (experi-
ment group 2, n = 10), or without DNA (control injection group,
n = 8); the fourth group was not injected (normal mice, n = 5). Injec-
tion via the tail vein enter into the circulation within 5–7 s. The injec-
tion with 50 lg of alb-Cre plasmid DNA was repeated 8 and 24 h later
for experiment group 5 (n = 6).
2.4. Histological procedures
At 1, 3, and 5 days after gene delivery, mice from each group were
euthanized, and the liver, brain, heart, lung, kidney, and spleen were
collected and assessed for the presence of green ﬂuorescence. The
remaining tissue was frozen in liquid nitrogen and stored for frozen
section and DNA assay. In addition, 5 days after gene delivery, liver
from each group of mice (n = 3) was perfused in situ through the portal
vein with either 0.05% collagenase dissolved in D-Hank’s solution (for
hepatocyte isolation) or 4.0% paraformaldehyde (for X-Gal staining
and immunoﬂuorescence). Isolation of hepatocytes was performed as
described by Lecocq et al. [21]. Brieﬂy, the perfused liver was gently
homogenized and further incubated in 0.025% collagenase for 30 min
at 37 C. This suspension was ﬁltered through stainless steel gauze
and centrifuged for 10 min at 50 · g to remove parenchymal cells, after
which the cells were cultured for the indicated time and prepared ﬂow
cytometry.
2.5. Visualization of EGFP
For collected organs, green ﬂuorescence was observed on a Leica
Wild M3C stereo microscope with an MAA-02 Universal light source
from BLS-Ltd. Tissue sections were viewed using a Leitz DMRB
microscope equipped with epiﬂuorescence lighting, using the FITC ﬁl-
ter set. All microscope samples were photographed using a Nikon E2
digital camera.
2.6. X-Gal staining
Frozen sections from organs including liver, lung, brain, heart, spleen
and kidney were stained by X-Gal using the method described previ-
ously [27]. Brieﬂy, sections were ﬁxed in phosphate-buﬀered saline
(PBS) containing 1% formaldehyde and 0.2% glutaraldehyde (Sigma).
lacZ expression was detected by in situ X-Gal staining. The sections
were incubated overnight in PBS with 5 mM potassium ferricyanide
(Sigma), 5 mM potassium ferrocyanide (Sigma), 2 mM MgCl2, and
1 g/L X-Gal (Sangon, Shanghai, China), washed twice with PBS, and
then dehydrated and mounted.2.7. Immunoﬂuorescence
Sections were incubated for 1 h in 1% H2O2 in PBS to inactivate
endogenous peroxidases and then rinsed twice for 20 min with PBS.
Sections were coincubated overnight at 4 C with a rabbit polyclonal
anti-Cre antibody at (1:1000) (Novagen, San Diego, CA) and a mouse
monoclonal anti-EGFP antibody at 1:400 (Diasorin, Stillwater, MN),
both in PBS/0.3% Triton X-100. After two washes with PBS for 20 min
at room temperature, sections were incubated in PBS/0.3% Triton X-
100 containing goat anti-mouse IgG coupled to ﬂuorescein at 1:400
(Boehringer Mannheim, Indianapolis, IN), and goat anti-rabbit IgG
coupled to rhodamine at 1:400 (Boehringer Mannheim). Finally, sec-
tions were washed twice in PBS for 20 min at room temperature,
mounted on microscope slides by ﬂoating them on PBS, and covers-
lipped under FluorSave reagent.
2.8. Southern blotting
Southern blotting was performed as described previously [28]. Total
DNA was isolated from liver, heart, spleen, kidney, lung, and brain tis-
sue using a standard phenol–chloroform extraction method. DNA was
digested with the restriction enzyme Xbal, electrophoresed through a
0.7% (w/v) agarose gel, and blotted onto a Magnacharge nylon mem-
brane (Frisenette, Ebeltoft, Denmark). The membrane was hybridized
with a 32P random-labeled neomycin probe (Amersham Pharmacia
Biotech Inc). The hybridized bands were visualized by autoradiogra-
phy.
2.9. Flow cytometry
Isolated hepatocytes were analyzed on a Becton Dickinson FAC-
Scan Flow Cytometer, using a 480-nm laser for excitation, 530-nm
emission for GFP, and FACS data were analyzed with FLOWJO soft-
ware (Tree Star, CA).
2.10. Liver toxicity assays
To monitor liver damage in mice that received plasmids or Ringer’s
solution, blood was collected at 1, 3, and 5 days after gene delivery.
Samples were analyzed for the levels of alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) by enzyme assay kits
(ALT/AST assay kit; KeHua, Shanghai, China). Histological examina-
tion was performed on formalin-ﬁxed mouse liver sections harvested at
various times following injection and prepared by routine histological
staining (hematoxylin/eosin) procedures.
2.11. Statistical analysis
The data are presented as the mean and standard error of the mean
for each group. Statistical analysis of the data were performed by Stu-
dent’s t-test using SigmaStat software (Jandel Scientiﬁc, San Rafael,
CA). A P value of less than 0.05 was considered signiﬁcant.3. Results
3.1. Cre-mediated gene expression in ROSA26 EGFP mice
We ﬁrst examined the resected specimens, including the
brain, heart, lung, kidney, liver, and spleen, by ﬂuorescence
stereoscopic microscopy. At 1 day after hydrodynamic deliv-
ery, expression of enhancer green ﬂuorescent protein (EGFP)
was not seen in any resected specimens from the various
groups. At 3 days after hydrodynamic delivery, low but deﬁ-
nite EGFP expression was ﬁrst seen only in the livers of mice
treated with alb-Cre plasmid DNA (50 lg and 10 lg), indicat-
ing recombination had occurred. On day 5 after hydrodynamic
delivery, expression of EGFP was markedly seen only in the
livers of mice treated with alb-Cre plasmid DNA (Fig. 1).
There are more cells expressing EGFP at 5 days than at 3 days
(Fig. 2A and B). This increase over time indicates that there is
a time-lag from Cre entry to gene expression and recombina-
tion. No EGFP expression was observed in the rest of the or-
gans of the experimental group, nor in any organs from
control animals that received the Ringer’s solution.
Fig. 1. Cre-mediated gene expression in ROSA26 EGFP reporter mice. EGFP expression was examined by ﬂuorescence stereoscopic microscopy in
organs from reporter mice 5 day after tail vein rapid injection of alb-Cre plasmid. Scale bar = 1 mm.
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reporter gene in the resected specimen, b-galactosidase gene
was identiﬁed by X-Gal staining of frozen sections. X-Gal
stained only the livers of the alb-Cre plasmid DNA injected
mice (Fig. 2C and D), but did not stain the livers of mice that
received only the Ringer’s solution (data not shown). This
ﬁnding agrees with the ﬁndings of Cre-mediated EGFP expres-
sion. The number of positive cells was greater with 50 lg than
with 10 lg alb-Cre plasmid DNA (Fig. 2C and D). Repeated
injection of 50 lg produced a further increase (Fig. 2E). It is
evident that under our experimental conditions, b-galactosi-
dase gene expression in the liver seems restricted to certain
areas, as X-Gal-positive cells clustered around the hepatic
vein. The distribution of the cells expressing the reporter gene
was heterogeneous, as some areas of the liver showed more po-
sitive cells than others. The reasons for the uneven distribution
are not understood. Uneven recombination or uneven expres-
sion of the recombined reported gene may be involved. No X-
Gal-positive cells were observed in the heart, lungs, kidney,
brain, or spleen of the alb-Cre plasmid DNA injected mice
(data not shown).
To further assess the Cre-mediated recombination, Southern
blotting was performed on genomic DNA from reporter mice
treated with alb-Cre plasmid DNA. Cre activity was reﬂected
by the conversion of the 10.3-kb ﬂoxed allele fragment into a
5.3-kb excised allele fragment. Fig. 2F shows that Cre recom-
bination occurred speciﬁcally in the liver of Cre-treated ani-
mals only. No recombination was observed in brain, heart,
lung, kidney, or spleen, in mice treated with alb-Cre plasmid
DNA. These results are consistent with the data described
above.
To determine whether Cre and EGFP were expressed within
the same cell, we performed double immunoﬂuorescence on
the frozen sections of the livers obtained from reporter mice
after alb-Cre plasmid DNA injection. Colocalization was iden-
tiﬁed by double immunoﬂuorescence using a mouse monoclo-
nal anti-EGFP antibody and a rabbit polyclonal anti-Cre
antiserum, followed by a ﬂuorescein-coupled anti-mouse IgG
antibody and a rhodamine-coupled anti-rabbit IgG antibody.
As expected, all cells that showed Cre expression were alsoEGFP positive (data not shown). In addition, the GFP and
Cre signals were predominantly localized to the nucleus, indi-
cating that Cre and EGFP were colocalized. This suggests that
Cre recombinase can be expressed in hepatocytes and mediates
recombination between the loxP sites to splice out the stuﬀer
sequence, thereby allowing EGFP reporter gene expression in
hepatocytes.
3.2. Cre-mediated recombination eﬃciency
The use of EGFP as the Cre reporter also allows the use of
ﬂow cytometry analysis for quantiﬁcation of cells that have
undergone Cre excision. To analyze the recombination eﬃ-
ciency in liver, hepatocytes were isolated from reporter mice
treated with alb-Cre plasmid or from untreated control repor-
ter mice. In mice injected with 50 lg DNA, 33.27% ± S.D.
3.55% (n = 3) of hepatocytes were EGFP positive; in mice in-
jected with 10 lg DNA, 7.38% ± S.D. 0.54% (n = 3) of hepato-
cytes were EGFP positive; whereas, in mice repeatedly injected
with 50 lg DNA 61.1% ± S.D. 3.5% (n = 3) of hepatocytes
were EGFP positive (Fig. 3).
3.3. Tests for liver damage
The potential toxic eﬀects of our procedure on animals were
assessed by a comprehensive clinical biochemical analysis. The
tests included the concentration of the liver speciﬁc enzymes –
AST and ALT. After the injection of Ringer’s solution with or
without plasmid DNA, the serum ALT of mice sharply in-
creased on day 1 after the injection and returned to normal lev-
els by day 5 (Table 1). A similar pattern was seen for serum
AST (Table 1). Histological sections of livers from each group
of mice showed no apparent pathological changes in the liver
sections of mice sacriﬁced on day 3 and day 5 after injection,
compared with the uninjected mice (data not shown).4. Discussion
Recent evidence demonstrates that hydrodynamic-based
gene delivery is a powerful tool for manipulating gene expres-
sion in liver. Accordingly, we sought to establish the feasibility
Fig. 2. Cre-mediated EGFP/b-galactosidase gene expression in liver of ROSA26 EGFP reporter mice. EGFP expression was examined by
ﬂuorescence stereoscopic microscopy in liver at 3 day (A), 5 day (B) after tail vein rapid injection of 50 lg alb-Cre plasmid. b-galactosidase gene
expression was examined by X-Gal stained on the frozen sections of the livers from reporter mice treated with 10 lg (C), 50 lg (D), and repeated
50 lg DNA (E). Southern blot analysis of Cre mediated excision in genomic DNA from heart (H), spleen (S), kidney (K), lung (L), liver (Li) and
brain (Br), in reporter mice treated with DNA; The sizes of ﬂoxed allele and excised allele are 10.3 kb and 5.3 kb (F), respectively. Scale bar: 250 lm
(A and B), 200 lm (C–E).
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tional gene targeting. Cre-mediated conditional gene targeting
requires precise knowledge of sites of recombination in order
to interpret mutant phenotypes. For this reason, we used the
ROSA26 EGFP strain as Cre recombinase reporter mice,
which enabled detection of recombination by ﬂuorescence
microscopy and X-gal staining to determine sites of Cre gene
expression in mouse. We observed that liver was the only
organ that expressed the EGFP/b-galactosidase gene at detect-
able levels after hydrodynamic injection of alb-Cre plasmid
DNA. Cells positive for EGFP and X-Gal were mainly local-
ized in areas surrounding the central vein. Our results are sim-
ilar to other reports [22,23] in which the lacZ gene and human
alpha1-antitrypsin gene expression after hydrodynamic injec-
tion were observed exclusively in the liver. Liver-speciﬁc gene
transfer probably results from a reﬂux of DNA solution into
the liver via the hepatic vein as a result of a transient cardiac
congestion. It may also be related to using liver-speciﬁc pro-
moters, such as the albumin promoter.To precisely analyze Cre-mediated recombination eﬃciency
in liver, we quantiﬁed cells from isolated hepatocytes with
EGFP by using ﬂow cytometry. Our data showed that Cre-
mediated recombination occurred in about 33% of hepatocytes
of the mice treated with 50 lg DNA using hydrodynamic gene
delivery, whereas only about 7% of hepatocytes of the mice
treated with 10 lg DNA were EGFP positive, indicating a
dose–response relationship between EGFP-positive cells and
the amount of injected DNA. Similarly, in a previous study
in which mice were subjected to hydrodynamic gene transfer,
approximately 40% of the cells in the liver expressed the lacZ
gene, and there is a clear correlation between the number of
X-gal-positive cells in each section and the amount of plasmid
DNA each animal received [19]. Recently, Song et al. [24] ver-
iﬁed delivery of synthetic siRNA duplexes into mouse hepato-
cytes in vivo by repeated hydrodynamic tail vein injection of
Cy5-labeled Fas siRNA. Twenty-four hours after the last of
three injections, 88 ± 6% of hepatocytes had taken up the siR-
NA and were Cy5-positive, as determined by ﬂow cytometry.
Fig. 3. Measurement of Cre-mediated EGFP expression in isolated hepatocytes by ﬂow cytometry. Hepatocytes from report mice treated without
DNA (A), or with 10 lg (B), 50 lg DNA (C) and repeated 50 lg DNA (D). The percentage indicated is the number of cells positive for EGFP
ﬂuorescence. Data represent means ± S.D. (n = 3).
Table 1
Eﬀect of the tail vein injection technique on serum concentration of ALT and AST
Time after injection (day) ALT (l/l) AST (l/l)
1 3 5 1 3 5
Experiment group 1 887 ± 54*** 64 ± 15** 26 ± 3 164 ± 32*** 88 ± 16** 68 ± 6
Experiment group 2 906 ± 44*** 68 ± 16** 25 ± 4 174 ± 36*** 89 ± 17** 67 ± 5
Control injection group 877 ± 48*** 62 ± 15** 23 ± 4 166 ± 33*** 85 ± 13** 70 ± 4
Normal mice 24 ± 2 23 ± 2 24 ± 2 66 ± 5 67 ± 3 66 ± 4
Note. The toxicity assay was assessed at various time points after tail vein quickly injection of experiment group1 (10 lg alb-Cre plasmid, n = 4),
experiment group 2 (50 lg alb-Cre plasmid, n = 4), control injection group (without DNA, n = 4), and normal mice (n = 4). Data represent
means ± S.D. **P < 0.05, ***P < 0.001, for comparisons with normal mice.
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served with a single injection of reporter plasmid DNA [19,20].
To further increase the eﬃciency of Cre-mediated recombina-
tion in our experiment, reporter mice were treated with re-
peated hydrodynamic tail injections. Our result showed that
Cre-mediated recombination reached about 61% of hepato-
cytes in the reporter mouse, indicating the feasibility of re-
peated hydrodynamic tail injections.
In transgenic mice carrying the Cre recombinase under the
control of a liver-speciﬁc promoter, the eﬃciency of recombi-
nation is only about 40% immediately after birth and is com-
plete by 6 weeks of age. To perform temporally controlled
hepatocyte-selective recombination of ﬂoxed genes, Tan-
nour-Louet et al. established a transgenic line expressing a
tamoxifen-inducible Cre recombinase under the control of
the transthyretin promoter. Recombination of ﬂoxed DNA
occurred in approximately 50% of hepatocytes after treat-
ment with 4-hydroxytamoxifen (4-OHT). Only after a series
of 4-OHT injections can the recombination eﬃciency reach
80–100% in the liver of these transgenic mice [9]. An alterna-
tive approach for the temporal regulation of the Cre activity
in the liver is to use adenoviruses carrying the Cre transgene.
Akagi et al. used an adeno Cre virus to monitor recombina-tion in vivo in LacZ reporter mice. Inoculation of 109 p.f.u.
vector into the tail vein resulted in massive staining of the
liver. About 65% of hepatocytes were stained by X-gal 5 days
after injection. However, the fraction of X-gal-positive hepa-
tocytes was reduced to 40, 4 and ﬁnally <1% of hepatocytes
on days 15, 30 and 60 post-injection, respectively, probably
as the result of the expression of viral functions on the vector
genomes resulting in host immune responses and loss of
transduced cells. Reduction of the virus dose to 106 p.f.u.
led to a much lower frequency of recombination [17]. To cir-
cumvent some of these problems, Badorf et al. used an aden-
oviral vector in which all viral coding sequences were absent.
With this vector, injection of 5 · 109 infectious units resulted
in recombination in approximately 10–20 % of hepatocytes
[18]. In addition, although adenoviral vectors expressing
Cre can transduce liver, other tissues are simultaneously in-
fected by this vector [17,18]. Therefore, compared with the
adenovirus approach, hydrodynamic gene delivery of Cre
recombinase more organ-speciﬁc.
We found that the ALT and AST values fell into a normal
range 5 days after injection. Animals injected with either Ring-
er’s solution or Ringer’s solution containing alb-Cre plasmid
DNA had an identical pattern of ALT changes, suggesting that
H.Z. Zhu et al. / FEBS Letters 580 (2006) 4346–4352 4351the increased ALT value is not caused by plasmid DNA or
gene products. Compared with normal mice that were not
injected, there were no obvious histological changes seen in
liver sections of animals injected with either Ringer’s solution
or Ringer’s solution containing diﬀerent amounts of alb-Cre
plasmid DNA. These results are consistent with previous
reports [19–23]. Importantly, these animals appear to recover
from such minor liver damage quickly, and thus hydrodynamic
Cre gene delivery appears to be safe.
However, recently in vitro and in vivo toxicity from Cre
recombinase has been reported [13,14,29,30]. The toxicity
seems to result from aberrant activity of Cre at ‘‘pseudo’’ loxP
sites. Loonstra et al. [14] demonstrated that this Cre toxicity
depends on expression levels. Cre was not toxic at low levels,
suggesting that transient expression of Cre should minimize
the chances of recombination at the endogenous pseudo-lox
sites and/or give the target cell time to repair the DNA damage
eﬃciently. Thus, compared with Cre transgenic mice, transient
expression of Cre may minimize its potential toxicity in mice
by hydrodynamic injection. In addition, Herweijer et al. [31]
have reported that a liver-speciﬁc albumin promoter is ex-
pressed at a much lower level of transgene product than are
viral promoters such as the CMV promoter. Consequently, a
Cre expression vector driven by the mouse albumin enhancer
and promoter also may minimize its potential toxicity.
One of the greatest advantages of this technique, compared
with other vector-mediated gene delivery systems such as viral
systems and transgenic technology, is that this simple technique
does not require long and laborious preparation of virus and
does not require any special devices for gene transfer. It elimi-
nates time-consuming and expensive breeding strategies, as
well as eliminating potentially complex genetic backgrounds
that result from transgenic approaches. With the progression
of human genome project, numerous hepatic genes with liver-
speciﬁc expression have been found, but their exact functions
are not clear. So far, many strains of mice with loxP-ﬂanked
genes of interest have been generated (see http://www.mshri.
on.ca/nagy/cre.htm). We believe that the use of hydrodynamic
gene delivery of Cre recombinase, in conjunction with mice
with loxP-ﬂanked genes of interest, may be a powerful tool to
rapidly study genes of interest in liver function and to create
mouse models for metabolic and liver diseases.
In summary, we have demonstrated that Cre recombinase
can be transferred to mouse livers via a simple hydrodynamic
gene-delivery approach and can mediate eﬃcient recombina-
tion in hepatocytes in mice. These results show that hydrody-
namic Cre gene delivery provides a simple, eﬃcient, and
inexpensive way of delivering Cre genes in vivo, as well as an
inexpensive way to study liver-related gene functions in vivo.
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